Skip to main content
. 2021 Jun 16;12(16):5053–5065. doi: 10.7150/jca.57752

Figure 6.

Figure 6

miR-30a inhibited EMT and CSC phenotypes in breast cancer in vivo. (A) Representative photographs of the xenograft tumors derived from subcutaneous implantation of MCF-7 miR-30a overexpressed and control cells on nude mice. (B) Growth curves of tumor. Values represent the mean ± SE. (C) Immunohistochemistry staining results of EMT-related, CSC-related, SOX4, and TGF-β/SMAD pathway related markers (× 200 magnification).